Namzaric® (memantine/donepezil) – Expanded indication
July 19, 2016 – Allergan and Adamas announced the FDA approval of Namzaric (memantine/ donepezil hydrochlorides) extended-release (ER) capsules, for the treatment of moderate to severe dementia of the Alzheimer’s type in patients stabilized on 10 mg of donepezil hydrochloride once daily.
Top